These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9271751)

  • 1. Hemostasis in aortic and cardiothoracic surgery.
    Shore-Lesserson L; Reich DL; Silvay G; Griepp RB
    J Card Surg; 1997; 12(2 Suppl):232-7. PubMed ID: 9271751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation disturbance in profound hypothermia: the influence of anti-fibrinolytic therapy.
    Westaby S
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):246-56. PubMed ID: 9263343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
    Hardy JF; Bélisle S
    Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552
    [No Abstract]   [Full Text] [Related]  

  • 5. Prohemostatic treatment in cardiac surgery.
    Levy JH; Sniecinski RM
    Semin Thromb Hemost; 2012 Apr; 38(3):237-43. PubMed ID: 22510857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifibrinolytics.
    Schmarts
    Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
    [No Abstract]   [Full Text] [Related]  

  • 9. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned in antifibrinolytic therapy: The BART trial.
    Murkin JM
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):127-31. PubMed ID: 19622534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical hemostatic agents in surgery: a surgeon's perspective.
    Samudrala S
    AORN J; 2008 Sep; 88(3):S2-11. PubMed ID: 18790097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of non-transfusional haemostatic agents.
    Cattaneo M; Mannucci PM
    Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
    [No Abstract]   [Full Text] [Related]  

  • 13. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin and hemostasis.
    Schisano G; Nina P
    J Neurosurg; 2005 Apr; 102(4):757-8; author reply 758. PubMed ID: 15871522
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery.
    Bidstrup BP
    Heart Lung Circ; 2007 Apr; 16(2):131. PubMed ID: 17317315
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.
    Porte RJ; Leebeek FW
    Drugs; 2002; 62(15):2193-211. PubMed ID: 12381219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suction, salvage, sutures, and potions: blood management post-aprotinin.
    Baker RA
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):122-6. PubMed ID: 19617252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative systemic haemostatic agents.
    Mahdy AM; Webster NR
    Br J Anaesth; 2004 Dec; 93(6):842-58. PubMed ID: 15277296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.